04:28 PM EDT, 09/12/2024 (MT Newswires) -- Richard E Lowenthal, 10% Owner, Director, President and CEO, on September 10, 2024, sold 100,000 shares in Ars Pharmaceuticals ( SPRY ) for $1,149,775. Following the Form 4 filing with the SEC, Lowenthal has control over a total of 10,669,106 shares of the company, with 4,315,313 shares held directly and 6,353,793 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1671858/000141588924023290/xslF345X05/form4-09122024_080915.xml